Basel, Switzerland

Andreas Kordikowski

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.9

ph-index = 1


Location History:

  • Basel, CH (2018)
  • Binningen, CH (2023 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Andreas Kordikowski

Introduction

Andreas Kordikowski is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for autoimmune diseases. With a total of six patents to his name, Kordikowski's work is recognized for its potential impact on healthcare.

Latest Patents

Kordikowski's latest patents include groundbreaking applications related to crystalline forms of a TLR7/TLR8 inhibitor. This application focuses on various crystalline forms of (S)—N-(4-((5-(1,6-dimethyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-3-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methyl)bicyclo[2.2.2]octan-1-yl)morpholine-3-carboxamide. These materials are particularly useful in treating various autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. Another significant patent involves crystalline forms of a LTA4H inhibitor, which addresses diseases and disorders typically ameliorated by the inhibition of LTA4H, including inflammatory and autoimmune disorders.

Career Highlights

Kordikowski is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing treatments that address complex health issues.

Collaborations

Throughout his career, Kordikowski has collaborated with talented individuals such as Siyi Jiang and Yudong Cao. These collaborations have fostered a productive environment for innovation and have led to the successful development of new therapeutic solutions.

Conclusion

Andreas Kordikowski's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to improving healthcare through scientific advancements. His contributions are paving the way for new treatments that can significantly enhance the quality of life for patients suffering from autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…